Document is current
Any future updates will be listed below
-
Authors
Norton, Nicholas
Nemeth, Zoltan
Nanda, Soumya
Dhirta, Abhishek
Geale, Kirk
Vaz, Raquel https://orcid.org/0000-0001-7518-1801
-
Funding
Funding for this research was provided by:
IFPA
Takeda Pharmaceutical Company
Almirall S.A.
- License Information
-
More Information
Article History
Received: 23 March 2026
Accepted: 22 May 2026
First Online: 5 June 2026
Declarations
:
: Nicholas Norton, Zoltan Nemeth, Soumya Nanda, Abhishek Dhirta and Kirk Geale are all employees of Quantify Research, an HEOR consultancy, which received funding from IFPA to conduct this study. Raquel Vaz is the scientific project lead of IFPA, which commissioned the project. Raquel Vaz has been a speaker at events hosted by Boehringer Ingelheim and Takeda Pharmaceuticals; consultant for Takeda Pharmaceuticals and Johnson and Johnson; and research grant holder from Takeda Pharmaceuticals. The authors declare no other conflicts of interest.
: This study did not involve human participants or animals and was based exclusively on data from previously published sources. Therefore, ethical approval and informed consent were not required. The research and reporting were conducted in accordance with the principles outlined in the International Committee of Medical Journal Editors (ICMJE) recommendations.
